Geographic Atrophy: The Good, The Bad, and The Frustrating

Editorially independent content, supported with advertising

In this Feature

The Good: Functional Vision, Small GA Lesion, Early Treatment

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Bad: Declining Vision in an Age Before Anti-Complement Therapy

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Frustrating: Rapid Atrophy Growth Despite Treatment

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

The Frustrating: IRF and SRF in a GA Patient

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

Interactive Supplements

GA in 2025: Dosing Regimens, Drug Selection, and Ideal Candidates

Listen Now

GA in 2025: Conversion to Wet AMD and Educating Patients on the Value of Continuing Therapy

Listen Now

About This Editorial Feature

Judy Kim, MD, moderates discussion as panelists Rishi Singh, MD; Sunir Garg, MD; and Deepak Sambhara, MD, share good, bad, and frustrating GA cases from their clinics as a framework to discuss modern dynamics in GA treatment.

Editorial Feature:

Geographic Atrophy: The Good, The Bad, and The Frustrating

In this Feature

Interactive Supplements